ORIGINAL RESEARCH
May 8
Adil Salihu et al.
This study evaluated the ability of ChatGPT-4, a large language model, to assist in the decision-making process of Multidisciplinary Heart Teams for the management of severe aortic stenosis, finding a 77% agreement rate with the Heart Team's decisions.
RESEARCH CORRESPONDENCE
May 8
Gennaro Giustino, Pedro A. Villablanca et al.
This study reports the outcomes of 22 patients with refractory cardiogenic shock who underwent transcaval venoarterial extracorporeal membrane oxygenation, with a 54.6% in-hospital mortality rate and a high incidence of vascular and bleeding complications.
EDITORIAL
May 8
Valentin Koch
A study examines the use of ChatGPT in augmenting the decision-making processes of Heart Teams in the treatment of severe aortic stenosis, suggesting a high degree of alignment between the language model and the multidisciplinary teams.
free
EDITORIAL
Apr 23
Harold L. Dauerman, Rony Lahoud et al.
This study examined the outcomes of 914 patients with severely reduced left ventricular ejection fraction (≤30%) who underwent TAVI, finding that prior myocardial infarction, reduced kidney function, and low-flow, low-gradient aortic stenosis were associated with higher mortality.
free
EDITORIAL
Apr 23
Barbara E. Stähli, Julia Stehli et al.
This substudy of the BIOVASC trial suggests that immediate multivessel PCI is an effective and safe strategy for ACS patients with multivessel coronary artery disease, including complex three-vessel disease.
free
Join the EuroIntervention Challenge
Apr 27
Participate in the EuroIntervention Challenge—an exciting test of your interventional cardiology knowledge and enthusiasm! Plus, stand a chance to win a free ticket to EuroPCR 2025!
ORIGINAL RESEARCH
Apr 23
Guy Witberg, Ran Kornowski et al.
This study assessed the likelihood of left ventricular recovery following transcatheter aortic valve implantation in patients with severe left ventricular dysfunction and severe aortic stenosis, and found that recovery was a major determinant of midterm mortality.
TRIAL DESIGN
Apr 23
Flavio Ribichini, Giuseppe Tarantini et al.
FAITAVI is a randomized trial comparing angiography-guided versus physiology-guided coronary revascularization in patients with severe aortic valve stenosis and coronary artery disease undergoing TAVI.
ORIGINAL RESEARCH
Apr 17
In patients with acute coronary syndrome and multivessel disease, immediate complete revascularization was non-inferior to staged revascularization in terms of the primary endpoint at 1 year, and was associated with a lower rate of myocardial infarction in those with three-vessel disease.
ORIGINAL RESEARCH
Apr 1
Jeroen M. Wilschut, Roberto Diletti, et al.
In STEMI patients with a prehospital large myocardial area at risk, administration of crushed prasugrel loading dose was associated with higher post-procedural TIMI 3 flow rates compared to integral prasugrel.
ORIGINAL RESEARCH
Mar 29
Kazuki Aihara, Gaku Nakazawa, et al.
This preclinical study compared the drug effects and safety of low-dose paclitaxel, regular-dose paclitaxel and sirolimus-coated drug-coated balloons when inflated in rabbit iliac arteries. Paclitaxel-coated balloons showed higher efficacy and lower distal embolization risk than the sirolimus-coated balloon.
Mar 18
Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.
Now, EuroIntervention is unveiling its new AI assistant – the first of its kind in the field of academic publishing - designed to accompany readers and enhance their reading experience.
EDITORIAL
Mar 18
Michael Joner; Léa Wild
A study compared three drug-coated balloon formulations in a porcine model, assessing drug transfer and tissue distribution as surrogates for clinical efficacy. Both paclitaxel formulations showed greater smooth muscle cell loss than the sirolimus formulation, but limitations were present.
free
DEBATE
Mar 18
Margaret B. McEntegart; Victoria Delgado et al.
Two large randomized trials found no benefit of an invasive strategy guided by ischaemia and viability testing over medical therapy alone for stable CAD patients, challenging the clinical usefulness of such testing.
free
Trending articles
Antiplatelet therapy after percutaneous coronary intervention
Transcatheter treatment for tricuspid valve disease
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Myocardial infarction with non-obstructive coronary artery disease
Management of in-stent restenosis
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology
Computed tomographic angiography in coronary artery disease
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
State-of-the-Art Review
10.4244/EIJ-D-21-00904
•
Apr 1, 2022
Angiolillo D et al
free
State-of-the-Art Review
10.4244/EIJ-D-21-00695
•
Nov 19, 2021
Praz F et al
free
Expert consensus
10.4244/EIJ-D-21-00898
•
Sep 20, 2022
Secemsky E et al
free
State-of-the-Art Review
10.4244/EIJ-D-21-00426
•
Dec 3, 2021
Lindahl B et al
free
State-of-the-Art Review
10.4244/EIJ-D-21-01034
•
Jun 3, 2022
Alfonso F et al
free
Expert review
10.4244/EIJ-D-21-00690
•
May 15, 2022
Moroni F et al
free
Expert consensus
10.4244/EIJ-D-23-00194
•
Aug 21, 2023
Escaned J et al
free
State-of-the-Art
10.4244/EIJ-D-22-00776
•
Apr 3, 2023
Serruys PW et al
free
Expert consensus
10.4244/EIJ-D-22-00958
•
May 12, 2023
Tarantini G et al
free
Expert consensus
10.4244/EIJ-E-22-00018
•
Dec 4, 2023
Lunardi M et al
free
